132 related articles for article (PubMed ID: 23477362)
1. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
Holtzman A; Flampouri S; Li Z; Mendenhall NP; Hoppe BS
Acta Oncol; 2013 Apr; 52(3):592-4. PubMed ID: 23477362
[No Abstract] [Full Text] [Related]
2. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.
Jørgensen AY; Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Rosenschöld PM; Petersen PM; Specht L
Acta Oncol; 2013 Oct; 52(7):1559-65. PubMed ID: 24047340
[TBL] [Abstract][Full Text] [Related]
3. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
6. Advancing (proton) radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):871-3. PubMed ID: 24267966
[No Abstract] [Full Text] [Related]
7. Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.
König L; Bougatf N; Hörner-Rieber J; Chaudhri N; Mielke T; Klüter S; Haefner MF; Rieken S; Haberer T; Debus J; Herfarth K
Strahlenther Onkol; 2019 Jul; 195(7):677-687. PubMed ID: 30972453
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
9. Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.
Sachsman S; Hoppe BS; Mendenhall NP; Holtzman A; Li Z; Slayton W; Joyce M; Sandler E; Flampouri S
Leuk Lymphoma; 2015 Jul; 56(7):2019-24. PubMed ID: 25315071
[TBL] [Abstract][Full Text] [Related]
10. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
[TBL] [Abstract][Full Text] [Related]
11. A decade of comparative dose planning studies for early-stage Hodgkin lymphoma: what can we learn?
Maraldo MV; Specht L
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1126-35. PubMed ID: 25539371
[TBL] [Abstract][Full Text] [Related]
12. Proton therapy and helical tomotherapy result in reduced dose deposition to the pancreas in the setting of cranio-spinal irradiation for medulloblastoma: implications for reduced risk of diabetes mellitus in long-term survivors.
Brower JV; Gans S; Hartsell WF; Goldman S; Fangusaro JR; Patel N; Lulla RR; Smiley NP; Chang JH; Gondi V
Acta Oncol; 2015 Apr; 54(4):563-6. PubMed ID: 25410591
[No Abstract] [Full Text] [Related]
13. Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients.
Andolino DL; Hoene T; Xiao L; Buchsbaum J; Chang AL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e667-71. PubMed ID: 21459527
[TBL] [Abstract][Full Text] [Related]
14. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
[TBL] [Abstract][Full Text] [Related]
17. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
18. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?
Ghalibafian M; Beaudre A; Girinsky T
Radiother Oncol; 2008 Apr; 87(1):82-8. PubMed ID: 18037182
[TBL] [Abstract][Full Text] [Related]
19. Consolidative active scanning proton therapy for mediastinal lymphoma: selection criteria, treatment implementation and clinical feasibility.
Dionisi F; Scartoni D; Rombi B; Vennarini S; Righetto R; Farace P; Lorentini S; Schwarz M; Di Murro L; Demofonti C; D'Angelillo RM; Petrongari MG; Sanguineti G; Amichetti M
Strahlenther Onkol; 2022 Jun; 198(6):558-565. PubMed ID: 35394144
[TBL] [Abstract][Full Text] [Related]
20. The contemporary use of radiation therapy in the management of lymphoma.
Boyle T; McPadden E
Surg Oncol Clin N Am; 2000 Jul; 9(3):621-37, xi. PubMed ID: 10853146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
